| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.43e-06 | 35 | 22 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.53e-04 | 288 | 22 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.30e-04 | 28 | 22 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 6.10e-04 | 153 | 22 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.27e-03 | 48 | 22 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.32e-03 | 49 | 22 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.54e-03 | 211 | 22 | 3 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.20e-03 | 239 | 22 | 3 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.62e-03 | 254 | 22 | 3 | GO:0043177 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 6.13e-03 | 107 | 22 | 2 | GO:0033293 | |
| GeneOntologyMolecularFunction | lipase activity | 1.00e-02 | 138 | 22 | 2 | GO:0016298 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.28e-02 | 157 | 22 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.41e-02 | 165 | 22 | 2 | GO:0140375 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.41e-02 | 873 | 22 | 4 | GO:0019901 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 5.88e-08 | 8 | 22 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.26e-07 | 10 | 22 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.30e-07 | 12 | 22 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.38e-06 | 21 | 22 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.70e-06 | 26 | 22 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.70e-06 | 26 | 22 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 7.99e-06 | 37 | 22 | 3 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.99e-06 | 37 | 22 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.67e-06 | 38 | 22 | 3 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.25e-05 | 52 | 22 | 3 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | 2.28e-04 | 1253 | 22 | 7 | GO:0044248 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 4.38e-04 | 141 | 22 | 3 | GO:0006805 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 5.87e-04 | 1035 | 22 | 6 | GO:0019752 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 6.13e-04 | 376 | 22 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 6.59e-04 | 1058 | 22 | 6 | GO:0043436 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 6.79e-04 | 1064 | 22 | 6 | GO:0006082 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 9.75e-06 | 40 | 22 | 3 | GO:0005640 | |
| Domain | UDPGT | 1.61e-06 | 21 | 21 | 3 | PS00375 | |
| Domain | UDPGT | 1.61e-06 | 21 | 21 | 3 | PF00201 | |
| Domain | UDP_glucos_trans | 1.61e-06 | 21 | 21 | 3 | IPR002213 | |
| Domain | PH | 2.06e-03 | 229 | 21 | 3 | PF00169 | |
| Domain | PH | 3.56e-03 | 278 | 21 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 3.59e-03 | 279 | 21 | 3 | PS50003 | |
| Domain | PH_domain | 3.63e-03 | 280 | 21 | 3 | IPR001849 | |
| Domain | - | 9.15e-03 | 391 | 21 | 3 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.15e-02 | 426 | 21 | 3 | IPR011993 | |
| Domain | SH3_1 | 1.44e-02 | 164 | 21 | 2 | PF00018 | |
| Domain | EF_Hand_1_Ca_BS | 1.63e-02 | 175 | 21 | 2 | IPR018247 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.61e-06 | 23 | 19 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.13e-06 | 24 | 19 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.69e-06 | 25 | 19 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.69e-06 | 25 | 19 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.69e-06 | 25 | 19 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.29e-06 | 26 | 19 | 3 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.66e-06 | 28 | 19 | 3 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.84e-05 | 39 | 19 | 3 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.14e-05 | 41 | 19 | 3 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.65e-05 | 44 | 19 | 3 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.84e-05 | 45 | 19 | 3 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.15e-05 | 51 | 19 | 3 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.40e-05 | 52 | 19 | 3 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.21e-05 | 55 | 19 | 3 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.21e-05 | 64 | 19 | 3 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.07e-04 | 70 | 19 | 3 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.17e-04 | 72 | 19 | 3 | M9257 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.55e-04 | 14 | 19 | 2 | M39328 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.83e-04 | 219 | 19 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.86e-04 | 220 | 19 | 4 | M10320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 2.04e-04 | 16 | 19 | 2 | M47449 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 2.12e-04 | 88 | 19 | 3 | M42580 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 2.31e-04 | 17 | 19 | 2 | M47560 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 2.60e-04 | 18 | 19 | 2 | M3430 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 2.60e-04 | 18 | 19 | 2 | MM1385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.56e-04 | 21 | 19 | 2 | M47542 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.77e-04 | 107 | 19 | 3 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 3.98e-04 | 109 | 19 | 3 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.98e-04 | 109 | 19 | 3 | M18788 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 5.07e-04 | 25 | 19 | 2 | MM1441 | |
| Pathway | REACTOME_DRUG_ADME | 5.15e-04 | 119 | 19 | 3 | MM15692 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 5.49e-04 | 26 | 19 | 2 | M17941 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 6.84e-04 | 29 | 19 | 2 | MM1495 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M9664 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 7.76e-04 | 137 | 19 | 3 | M5669 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 8.33e-04 | 32 | 19 | 2 | MM1355 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 8.86e-04 | 33 | 19 | 2 | M9494 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.24e-03 | 39 | 19 | 2 | M1908 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.24e-03 | 39 | 19 | 2 | MM1397 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.43e-03 | 42 | 19 | 2 | MM1504 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.57e-03 | 44 | 19 | 2 | M19784 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.79e-03 | 183 | 19 | 3 | M39588 | |
| Pathway | WP_RANKLRANK_SIGNALING | 2.45e-03 | 55 | 19 | 2 | M39667 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 2.72e-03 | 58 | 19 | 2 | MM14914 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.40e-03 | 65 | 19 | 2 | M272 | |
| Pathway | WP_TH17_CELL_DIFFERENTIATION_PATHWAY | 3.83e-03 | 69 | 19 | 2 | M45541 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.16e-03 | 72 | 19 | 2 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.27e-03 | 73 | 19 | 2 | MM15906 | |
| Pubmed | 7.68e-09 | 7 | 22 | 3 | 26074487 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 32093886 | ||
| Pubmed | 1.23e-08 | 8 | 22 | 3 | 10748067 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 17263731 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 15319348 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 10222050 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7835904 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8333863 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 22092298 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 29138287 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 16849011 | ||
| Pubmed | Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca2+ signaling. | 2.29e-06 | 4 | 22 | 2 | 19285079 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10024527 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 15318931 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 18052087 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 18719240 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 20142249 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 18161889 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.51e-05 | 12 | 22 | 2 | 20308471 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 20056724 | ||
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 20379146 | ||
| Pubmed | 1.87e-04 | 32 | 22 | 2 | 23986795 | ||
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 2.65e-04 | 38 | 22 | 2 | 12482669 | |
| Pubmed | Identification of transcripts with enriched expression in the developing and adult pancreas. | 5.81e-04 | 624 | 22 | 4 | 18554416 | |
| Cytoband | 4q13 | 2.29e-05 | 15 | 22 | 2 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 5.76e-05 | 157 | 22 | 3 | chr4q13 | |
| GeneFamily | UDP glucuronosyltransferases | 3.37e-06 | 32 | 17 | 3 | 363 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.81e-04 | 206 | 17 | 3 | 682 | |
| GeneFamily | EF-hand domain containing | 1.76e-02 | 219 | 17 | 2 | 863 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.17e-05 | 53 | 22 | 3 | MM1203 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 8.60e-05 | 103 | 22 | 3 | MM919 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.39e-04 | 121 | 22 | 3 | MM935 | |
| Coexpression | SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN | 1.40e-04 | 21 | 22 | 2 | M41206 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 1.51e-04 | 330 | 22 | 4 | MM1120 | |
| Coexpression | SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP | 1.68e-04 | 23 | 22 | 2 | M41207 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-non-classical_monocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.96e-05 | 123 | 22 | 3 | 2a5e3c579f4b390c0a0d6d81c0a94c1b00dcbd85 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-05 | 167 | 22 | 3 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.01e-05 | 172 | 22 | 3 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.01e-05 | 172 | 22 | 3 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.29e-05 | 174 | 22 | 3 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.29e-05 | 174 | 22 | 3 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 9.17e-05 | 180 | 22 | 3 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.17e-05 | 180 | 22 | 3 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 9.32e-05 | 181 | 22 | 3 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.79e-05 | 184 | 22 | 3 | 95cf125127658c4c04445c61809d1aed21ee1f83 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 22 | 3 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 22 | 3 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-04 | 187 | 22 | 3 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-04 | 187 | 22 | 3 | 160e5f338537d90d50f863a1be801b1071ac7da7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-04 | 189 | 22 | 3 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 190 | 22 | 3 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | critical-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-04 | 194 | 22 | 3 | eeae611ab72d602fb545c729a14ef38ce5c47f2c | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.16e-04 | 195 | 22 | 3 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.23e-04 | 199 | 22 | 3 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.25e-04 | 200 | 22 | 3 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| Computational | Steroid hormone and heme metabolism. | 5.91e-07 | 16 | 12 | 3 | MODULE_505 | |
| Computational | Genes in the cancer module 227. | 1.19e-04 | 15 | 12 | 2 | MODULE_227 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.25e-08 | 29 | 21 | 4 | CID000125641 | |
| Drug | 2-hydroxyestriol | 1.35e-08 | 6 | 21 | 3 | CID000014688 | |
| Drug | BP-3,6-quinol | 2.15e-08 | 33 | 21 | 4 | CID000119292 | |
| Drug | 7-methoxycoumarin | 2.05e-07 | 57 | 21 | 4 | CID000010748 | |
| Drug | 4-hydroxybiphenyl | 2.35e-07 | 59 | 21 | 4 | CID000007103 | |
| Drug | 3-OHBaP | 3.07e-07 | 63 | 21 | 4 | CID000025890 | |
| Drug | methoxyresorufin | 4.45e-07 | 69 | 21 | 4 | CID000119220 | |
| Drug | C1 11-32 | 5.47e-07 | 18 | 21 | 3 | CID000443077 | |
| Drug | C11131 | 5.47e-07 | 18 | 21 | 3 | CID000443076 | |
| Drug | 7-hydroxycoumarin | 6.23e-07 | 75 | 21 | 4 | CID005281426 | |
| Drug | T4-G | 6.49e-07 | 19 | 21 | 3 | CID000152424 | |
| Drug | benzyloxyresorufin | 7.30e-07 | 78 | 21 | 4 | CID000114982 | |
| Drug | N'-nitrosoanatabine | 7.63e-07 | 20 | 21 | 3 | CID000051291 | |
| Drug | estriol-16-glucuronide | 8.90e-07 | 21 | 21 | 3 | CID000122281 | |
| Drug | N'-nitrosoanabasine | 1.03e-06 | 22 | 21 | 3 | CID000014335 | |
| Drug | 7-ethoxycoumarin | 1.08e-06 | 86 | 21 | 4 | CID000035703 | |
| Drug | pentoxyresorufin | 1.13e-06 | 87 | 21 | 4 | CID000107683 | |
| Drug | estradiol-3-glucuronide | 1.18e-06 | 23 | 21 | 3 | CID000066651 | |
| Drug | p-nitroanisole | 1.42e-06 | 92 | 21 | 4 | CID000007485 | |
| Drug | ethoxyresorufin | 1.61e-06 | 95 | 21 | 4 | CID000003294 | |
| Drug | DCNB | 1.61e-06 | 95 | 21 | 4 | CID000007443 | |
| Drug | 1-naphthol | 1.83e-06 | 98 | 21 | 4 | CID000007005 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 2.12e-06 | 238 | 21 | 5 | CID000001027 | |
| Drug | L-idaro-1,4-lactone | 2.18e-06 | 28 | 21 | 3 | CID000078997 | |
| Drug | 5 alpha-dihydroaldosterone | 2.43e-06 | 3 | 21 | 2 | CID003036614 | |
| Drug | NNAL | 3.30e-06 | 32 | 21 | 3 | CID000104856 | |
| Drug | morphine hydrochloride | 3.57e-06 | 481 | 21 | 6 | CID000004253 | |
| Drug | AC1Q6OQG | 3.62e-06 | 33 | 21 | 3 | CID000009686 | |
| Drug | AC1Q7AUJ | 3.70e-06 | 117 | 21 | 4 | CID000003303 | |
| Drug | fibrates | 3.83e-06 | 118 | 21 | 4 | CID000002797 | |
| Drug | alpha-naphthoflavone | 3.83e-06 | 118 | 21 | 4 | CID000011790 | |
| Drug | benzphetamine | 3.96e-06 | 119 | 21 | 4 | CID000002341 | |
| Drug | AC1NOWCJ | 4.34e-06 | 35 | 21 | 3 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 4.34e-06 | 35 | 21 | 3 | CID010436171 | |
| Drug | estrone-3-glucuronide | 4.34e-06 | 35 | 21 | 3 | CID000115255 | |
| Drug | hexobarbital | 5.13e-06 | 127 | 21 | 4 | CID000003608 | |
| Drug | l-borneol | 5.15e-06 | 37 | 21 | 3 | CID000010049 | |
| Drug | harmol | 6.54e-06 | 40 | 21 | 3 | CID000068094 | |
| Drug | 2-AF | 7.05e-06 | 41 | 21 | 3 | CID000005800 | |
| Drug | testosterone glucuronide | 7.05e-06 | 41 | 21 | 3 | CID000108192 | |
| Drug | PTBP | 7.59e-06 | 42 | 21 | 3 | CID000007393 | |
| Drug | clofibrate | 7.83e-06 | 311 | 21 | 5 | CID000002796 | |
| Drug | aniline | 7.99e-06 | 142 | 21 | 4 | CID000006115 | |
| Drug | phenolphthalin | 8.09e-06 | 5 | 21 | 2 | CID000066494 | |
| Drug | hyodeoxycholic acid | 8.09e-06 | 5 | 21 | 2 | ctd:C010471 | |
| Drug | Amobarbital | 8.09e-06 | 5 | 21 | 2 | ctd:D000654 | |
| Drug | androsterone glucuronide | 8.15e-06 | 43 | 21 | 3 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 8.15e-06 | 43 | 21 | 3 | CID000009191 | |
| Drug | 2 E1 | 8.68e-06 | 145 | 21 | 4 | CID006102788 | |
| Drug | MS-222 | 8.74e-06 | 44 | 21 | 3 | CID000011400 | |
| Drug | salicylamide | 1.14e-05 | 48 | 21 | 3 | CID000005147 | |
| Drug | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol | 1.21e-05 | 6 | 21 | 2 | ctd:C475721 | |
| Drug | 4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid | 1.21e-05 | 6 | 21 | 2 | ctd:C099564 | |
| Drug | AC1NQGK1 | 1.45e-05 | 52 | 21 | 3 | CID005195977 | |
| Drug | oxazepam | 1.54e-05 | 53 | 21 | 3 | CID000004616 | |
| Drug | aminopyrine | 1.66e-05 | 171 | 21 | 4 | CID000006009 | |
| Drug | oxazepam glucuronide | 1.70e-05 | 7 | 21 | 2 | CID000160870 | |
| Drug | ranirestat | 1.70e-05 | 7 | 21 | 2 | ctd:C115070 | |
| Drug | 4-nitrophenol | 1.91e-05 | 177 | 21 | 4 | CID000000980 | |
| Drug | phenolphthalein | 2.02e-05 | 58 | 21 | 3 | CID000004764 | |
| Drug | urochloralic acid | 2.13e-05 | 59 | 21 | 3 | CID003036914 | |
| Drug | 4-hydroxyestrone | 2.13e-05 | 59 | 21 | 3 | CID000018418 | |
| Drug | SN-38G | 2.13e-05 | 59 | 21 | 3 | CID000443154 | |
| Drug | acetaminophen glucuronide | 2.13e-05 | 59 | 21 | 3 | CID000083944 | |
| Drug | UDP-alpha-d-xylopyranose | 2.24e-05 | 60 | 21 | 3 | CID000001165 | |
| Drug | DNCB | 2.46e-05 | 189 | 21 | 4 | CID000000006 | |
| Drug | anethole trithione | 2.59e-05 | 63 | 21 | 3 | CID000002194 | |
| Drug | N'-nitrosonornicotine | 2.59e-05 | 63 | 21 | 3 | CID000027919 | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | 2.79e-05 | 195 | 21 | 4 | 5763_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 2.79e-05 | 195 | 21 | 4 | 4326_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 3766_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 3762_DN | |
| Drug | dimethylnitrosamine | 2.84e-05 | 196 | 21 | 4 | CID000006124 | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 4236_DN | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 5805_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 2651_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 4550_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 7526_DN | |
| Drug | beta-naphthoflavone | 3.08e-05 | 200 | 21 | 4 | CID000002361 | |
| Drug | Meldola | 3.26e-05 | 68 | 21 | 3 | CID000081507 | |
| Drug | nitrosamine | 3.56e-05 | 70 | 21 | 3 | CID000037183 | |
| Drug | diclofenac | 3.65e-05 | 209 | 21 | 4 | CID000003032 | |
| Drug | Aroclor 1254 | 3.93e-05 | 213 | 21 | 4 | CID000040470 | |
| Drug | 2,2,2-trichloroethanol | 4.03e-05 | 73 | 21 | 3 | CID000008259 | |
| Drug | eugenol | 4.03e-05 | 73 | 21 | 3 | CID000003314 | |
| Drug | 1,4-benzodiazepine | 4.43e-05 | 11 | 21 | 2 | CID000148431 | |
| Drug | zomepirac | 4.43e-05 | 11 | 21 | 2 | CID000005733 | |
| Drug | 16-epiestriol | 4.73e-05 | 77 | 21 | 3 | CID000003269 | |
| Drug | AC1N8H7N | 4.92e-05 | 78 | 21 | 3 | CID004318740 | |
| Drug | AC1L1BH2 | 4.92e-05 | 78 | 21 | 3 | CID000001436 | |
| Drug | 3-methylcholanthrene | 5.40e-05 | 231 | 21 | 4 | CID000001674 | |
| Drug | acridine | 5.51e-05 | 81 | 21 | 3 | CID000009215 | |
| Drug | 1zz2 | 5.71e-05 | 82 | 21 | 3 | CID005287728 | |
| Drug | 5 alpha-androstane | 6.14e-05 | 84 | 21 | 3 | CID000094144 | |
| Drug | cotinine-N-glucuronide | 6.28e-05 | 13 | 21 | 2 | CID000000411 | |
| Drug | menthol | 6.82e-05 | 87 | 21 | 3 | CID000001254 | |
| Drug | tiaprofenic acid | 7.32e-05 | 14 | 21 | 2 | CID000005468 | |
| Drug | propranolol glucuronide | 7.32e-05 | 14 | 21 | 2 | CID000119515 | |
| Drug | 4-aminobiphenyl | 8.06e-05 | 92 | 21 | 3 | CID000007102 | |
| Drug | 2-naphthol | 8.32e-05 | 93 | 21 | 3 | CID000008663 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.60e-08 | 9 | 21 | 3 | EFO_0600040 | |
| Disease | vanillylmandelate (VMA) measurement | 1.01e-05 | 7 | 21 | 2 | EFO_0800119 | |
| Disease | deoxycholic acid glucuronide measurement | 1.35e-05 | 8 | 21 | 2 | EFO_0800575 | |
| Disease | X-19141 measurement | 3.75e-05 | 13 | 21 | 2 | EFO_0800799 | |
| Disease | X-24947 measurement | 1.10e-04 | 22 | 21 | 2 | EFO_0800910 | |
| Disease | testosterone measurement | 1.99e-04 | 1275 | 21 | 6 | EFO_0004908 | |
| Disease | vitamin D deficiency | 3.16e-04 | 37 | 21 | 2 | EFO_0003762 | |
| Disease | vitamin D measurement, COVID-19 | 5.56e-04 | 49 | 21 | 2 | EFO_0004631, MONDO_0100096 | |
| Disease | disease progression measurement | 8.61e-04 | 61 | 21 | 2 | EFO_0008336 | |
| Disease | Manic Disorder | 1.16e-03 | 71 | 21 | 2 | C0024713 | |
| Disease | Manic | 1.40e-03 | 78 | 21 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 1.44e-03 | 79 | 21 | 2 | C0005587 | |
| Disease | vitamin D measurement | 1.67e-03 | 336 | 21 | 3 | EFO_0004631 | |
| Disease | pursuit maintenance gain measurement | 3.44e-03 | 123 | 21 | 2 | EFO_0008433 | |
| Disease | serum gamma-glutamyl transferase measurement | 3.59e-03 | 914 | 21 | 4 | EFO_0004532 | |
| Disease | acylcarnitine measurement | 3.66e-03 | 127 | 21 | 2 | EFO_0005059 | |
| Disease | Bipolar Disorder | 4.50e-03 | 477 | 21 | 3 | C0005586 | |
| Disease | metabolite measurement | 7.01e-03 | 560 | 21 | 3 | EFO_0004725 | |
| Disease | HMG CoA reductase inhibitor use measurement | 7.91e-03 | 189 | 21 | 2 | EFO_0009932 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IWQKFFLLYLHRPGP | 1311 | Q9HCE0 | |
| VDWQHVYLQKYPPPL | 456 | P35626 | |
| FVNPAPPYLWPAHKN | 116 | O00468 | |
| YLYPLQWQHPFVPIL | 236 | A2RUS2 | |
| LPWPYERGFLLHQKI | 276 | Q6UXT9 | |
| WKRPPELHSNPQFYF | 71 | A8MX76 | |
| PFPHIFEPFYIPDKW | 366 | P21953 | |
| YLAVPQHPYQWAKPK | 386 | O95644 | |
| PPKYHLLPVFPSFWI | 206 | Q0VF49 | |
| NFHNFLAWPFPNLPP | 281 | P48551 | |
| WLHRNPKYFPEPELF | 371 | Q9NYL5 | |
| LRKLYLEGNPLWFHP | 281 | Q8N1F8 | |
| PNQLKPPWSNFYHLN | 51 | Q8IW52 | |
| WLPFHIFFLLPYINP | 261 | P25103 | |
| NPNQPFYILHPKFIW | 401 | Q96JF0 | |
| EPLPLPFHQWFLKNY | 236 | Q8TF17 | |
| YWDFQFPHPLLPNVE | 261 | P06133 | |
| PETPKWFHLPYLFQM | 136 | O60667 | |
| LNPVWPAKPFHFQIS | 1136 | P19174 | |
| APLFLPQHHFLWYVK | 926 | Q9ULM0 | |
| WNFKFPHPFLPNVDF | 261 | P36537 | |
| SWNFQFPYPLLPNVD | 261 | P16662 |